Tumour vasculature as a target for cancer therapy

[1] BIOREDUCTIVE DRUGS FOR CANCER-THERAPY - THE SEARCH FOR TUMOR SPECIFICITY [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (02): : 231 - 238

[2] Retroviral display of antibody fragments; Interdomain spacing strongly influences vector infectivity [J]. HUMAN GENE THERAPY, 1996, 7 (17) : 2157 - 2164

[3] HUMAN VON-WILLEBRAND-FACTOR GENE-SEQUENCES TARGET EXPRESSION TO A SUBPOPULATION OF ENDOTHELIAL-CELLS IN TRANSGENIC MICE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) : 4567 - 4571

[4] ALGIRE GH, 1954, J NATL CANCER I, V14, P879

[5] Gene therapeutic approach to primary and metastatic brain tumors .1. CD44 variant pre-RNA alternative splicing as a CEPT control element [J]. JOURNAL OF NEURO-ONCOLOGY, 1995, 26 (03) : 243 - 250

[6] INHIBITION OF GROWTH OF COLON-38 ADENOCARCINOMA BY VINBLASTINE AND COLCHICINE - EVIDENCE FOR A VASCULAR MECHANISM [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (04) : 482 - 487

[7] Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (11) : 1761 - 1767

[8] REDUCTION OF TUMOR BLOOD-FLOW BY FLAVONE ACETIC-ACID - A POSSIBLE COMPONENT OF THERAPY [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (03) : 216 - 222

[9] Studies in tissue metabolism IX. The action of colchicine and B. typhosus extract [J]. BIOCHEMICAL JOURNAL, 1937, 31 : 454 - 460

[10] ADENOVIRUS-MEDIATED IN-VIVO GENE-TRANSFER [J]. GENE THERAPY FOR NEOPLASTIC DISEASES, 1994, 716 : 90 - 103

[1] BIOREDUCTIVE DRUGS FOR CANCER-THERAPY - THE SEARCH FOR TUMOR SPECIFICITY [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (02): : 231 - 238

[2] Retroviral display of antibody fragments; Interdomain spacing strongly influences vector infectivity [J]. HUMAN GENE THERAPY, 1996, 7 (17) : 2157 - 2164

[3] HUMAN VON-WILLEBRAND-FACTOR GENE-SEQUENCES TARGET EXPRESSION TO A SUBPOPULATION OF ENDOTHELIAL-CELLS IN TRANSGENIC MICE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) : 4567 - 4571

[4] ALGIRE GH, 1954, J NATL CANCER I, V14, P879

[5] Gene therapeutic approach to primary and metastatic brain tumors .1. CD44 variant pre-RNA alternative splicing as a CEPT control element [J]. JOURNAL OF NEURO-ONCOLOGY, 1995, 26 (03) : 243 - 250

[6] INHIBITION OF GROWTH OF COLON-38 ADENOCARCINOMA BY VINBLASTINE AND COLCHICINE - EVIDENCE FOR A VASCULAR MECHANISM [J]. EUROPEAN JOURNAL OF CANCER, 1991, 27 (04) : 482 - 487

[7] Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (11) : 1761 - 1767

[8] REDUCTION OF TUMOR BLOOD-FLOW BY FLAVONE ACETIC-ACID - A POSSIBLE COMPONENT OF THERAPY [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (03) : 216 - 222

[9] Studies in tissue metabolism IX. The action of colchicine and B. typhosus extract [J]. BIOCHEMICAL JOURNAL, 1937, 31 : 454 - 460

[10] ADENOVIRUS-MEDIATED IN-VIVO GENE-TRANSFER [J]. GENE THERAPY FOR NEOPLASTIC DISEASES, 1994, 716 : 90 - 103